Report: Private-sector support crucial to drug R&D

06/24/2008 | San Diego Union-Tribune · New York Sun, The

Many drugs "would have been delayed significantly" or would not have been developed without funding and expertise from drug companies, according to a Manhattan Institute for Public Policy report released Tuesday. The report -- based on case histories of 35 popularly prescribed medicines -- counters criticism that drugmakers have capitalized on government-backed research discoveries, only to produce new versions of existing therapies instead of innovative treatments, the lead author said.

View Full Article in:

San Diego Union-Tribune · New York Sun, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Corporate Counsel - Healthcare Law Group
Genentech
South San Francisco, CA
Manager/Senior Manager, Health Services Analytics
Avalere Health
Washington, DC